Position in SANA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$39,098,937
+$8,749,250 QoQ
Shares Held
11,203,134
+6.3% QoQ
Ownership
3.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. SANA ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,098,937 | 11,203,134 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $30,349,687 | 10,538,086 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,783,202 | 8,054,841 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $23,715,920 | 6,680,541 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,808,138 | 2,860,124 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,227,455 | 5,492,533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,936,747 | 6,709,661 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $27,569,651 | 6,627,320 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,714,931 | 6,358,046 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $63,701,650 | 6,370,165 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,107,442 | 5,908,687 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,834,867 | 4,608,493 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,833,305 | 4,837,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,617,352 | 5,693,380 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,815,566 | 6,788,751 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $39,288,492 | 6,548,082 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $55,262,075 | 8,594,413 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $59,066,681 | 7,150,930 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $54,742,527 | 3,536,339 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $59,824,605 | 2,656,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $38,856,849 | 1,976,442 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,067,558 | 211,161 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||